Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
Ischemic-type biliary lesions (ITBLs) are a major cause of graft loss and mortality after
orthotopic liver transplantation (OLT). For now, there are still lacking effective treatment
for ITBLs. The purpose of this study is to confirm whether human umbilical cord mesenchymal
stem cells are effective in the treatment,or prevention of Ischemic-type Biliary Lesions
after liver transplantation.